Whitepaper: Alpha Technologies for Antibody Detection and Characterization

Therapeutic proteins, namely antibodies, are growing in importance in many drug discovery pipelines. Since the last decade, many therapeutic antibodies were approved by the FDA. Many laboratories developing and producing antibodies still rely on traditional enzyme-linked immunosorbent assay (ELISA) to perform clonal selection and characterization despite the fact that this proven technology often suffers from a number of limitations. Here …